Original site: www.cdc.gov/viral-hemorrhagic-fevers/hcp/clinical-care/index.html
RestoredCDC.org is an independent project and is not affiliated with, endorsed by, or associated with the Centers for Disease Control and Prevention (CDC) or any government entity. The CDC provides information free of change at CDC.gov. Note the following: 1) Due to archival on January 6, 2025, no information on recent outbreaks is available. 2) Videos have not been restored. 3) Use of this site implies acceptance of this disclaimer.
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
Clinical Treatment of Viral Hemorrhagic Fevers (VHFs)
- Healthcare providers should notify their health department and CDC to determine a patient's course of treatment.
- FDA-approved therapeutics do not exist for most viral hemorrhagic fevers.
- Supportive care is vital for patients with suspected or confirmed VHFs.
- Special precautions are needed to safely provide care like hemodialysis to VHF patients.
